Hexagon Nutrition Lists at 7% Premium: Check Key Highlights
Hexagon Nutrition shares made their stock market debut today by listing at a 7% premium today, June 12, 2026, on both the BSE and NSE.
The share price of Hexagon Nutrition was listed on the NSE at ₹48.25, which is ₹3.25, or 7.22%, more than the ₹45 offer price. In the meantime, the stock opened at ₹48 on the BSE, up ₹3 or 6.67%.
The listing comes after the company's initial public offering (IPO) received strong investor participation across categories, generating significant interest among market participants.
The IPO was open for bidding from June 5 to June 9, 2026, while the basis of allotment was finalised on June 10.
The listing gains closely meet the Grey Market Premium (GMP) estimates, an unofficial indicator of investor sentiment.
Hexagon Nutrition IPO GMP
According to media reports, Hexagon Nutrition's grey market premium (GMP) stood at around ₹2.75 per share ahead of its listing.
However, investors should note that GMP is an unofficial indicator and may not accurately predict actual listing performance.
Hexagon Nutrition IPO Overall Subscription
The ₹138.87 crore IPO attracted robust demand during the bidding period, with the issue being subscribed 53.68 times overall. Demand was led overwhelmingly by non-institutional investors (NIIs), who subscribed their portion 161.49 times, followed by retail investors at 26.85 times. Qualified institutional buyers (QIBs), however, showed comparatively muted interest, subscribing their quota 19.77 times.
The issue was available in a price band of ₹42-₹45 per share and was entirely an Offer for Sale (OFS), meaning the proceeds from the issue will go to existing shareholders rather than the company.
What Investors Should Note
The Hexagon Nutrition stock increased gains to hit the 5% upper price band soon after its debut. On NSE, it rose to ₹50.66 and on BSE to ₹50.39.
Investors who received allotment may keep an eye overall market sentiment during the first few hours of trading.
While grey market signals suggest a positive debut, the expected gains appear relatively modest compared to several recent IPO listings.
For long-term investors, the focus is likely to remain on the company's growth prospects in the nutrition and wellness sector, profitability trends, and ability to expand its product portfolio and market presence.
As always, listing-day volatility can be high, and investors should make decisions based on their investment goals and risk appetite rather than relying solely on GMP trends.
Hexagon Nutrition IPO - Issue Details
- Issue Type: Book Building IPO
- Total Issue Size: ₹138.87 crore
- Offer for Sale (OFS): 3.09 crore equity shares
- Face Value: ₹1 per equity share
- Price Band: ₹42 to ₹45 per share
- Lot Size: 333 shares
- Listing: NSE, BSE
- Book Building Lead Managers: Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited.
- Registrar: KFin Technologies Limited
About Hexagon Nutrition Limited
Incorporated in 1993, Hexagon Nutrition Limited is a research-driven nutrition company engaged in the development and manufacturing of therapeutic nutrition products, micronutrient premixes, wellness solutions, and ready-to-use food products.
The company's product portfolio includes clinical nutrition and branded wellness products for consumers (B2C), premix formulation solutions for businesses (B2B2C), as well as ready-to-use foods (RUFs) and micronutrient powders (MNPs) aimed at addressing nutritional deficiencies.
For FY25, Hexagon Nutrition reported revenue from operations of ₹324.9 crore and a net profit of ₹24.3 crore, compared with revenue of ₹297.7 crore and a net profit of ₹12.2 crore in FY24. For the nine months ended December 31, 2025, the company posted revenue from operations of ₹267.5 crore and a profit after tax of ₹27.03 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.